IMMODULON THERAPEUTICS
Live / Registered — International registration cancelled — extension of protection cancelled (as of 30 Jul 2021)
What this means for you
Registered since 26 Mar 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79102506
- Registration number
- 4307164
- Mark type
- Design + words
- Filed
- 29 Jul 2011
- Published for opposition
- 08 Jan 2013
- Registered
- 26 Mar 2013
- Attorney of record
- Lynn M. Jordan,
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation
- Class 044 — Medical, beauty and agricultural services: Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition
Owner
- Immodulon Therapeutics Limited, London, GB
- Immodulon Therapeutics Limited, London, GB
- Immodulon Therapeutics Limited, London, GB
Prosecution history
- 19 Feb 2022 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 19 Feb 2022 — DEATH OF INTERNATIONAL REGISTRATION
- 12 Sept 2020 — TOTAL INVALIDATION PROCESSED BY THE IB
- 12 Aug 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 12 Aug 2020 — INVALIDATION PROCESSED
- 01 Jul 2020 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 01 Nov 2019 — CANCELLED SECTION 71
- 26 Mar 2018 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 30 Jan 2015 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Dec 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Dec 2013 — FINAL DISPOSITION NOTICE SENT TO IB
- 02 Dec 2013 — FINAL DISPOSITION PROCESSED
- 26 Jun 2013 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Mar 2013 — REGISTERED-PRINCIPAL REGISTER
- 14 Jan 2013 — NOTIFICATION PROCESSED BY IB